Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Mycophenolic acid

Inosine-5’-monophosphate dehydrogenase inhibitor
BML-A249-0100 100 mg 69.00 USD
BML-A249-0500 500 mg 275.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-380-015

Antiviral and immunosuppressive activity. Clinically useful antipsoriatic agent. Mycophenolic acid prodrugs are effective in rheumatoid arthritis and for the prevention of organ transplant rejection. Mechanism of action is inhibition of inosine-5'-monophosphate dehydrogenase.

Product Specification

Alternative Name:6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic acid
Source:Isolated from Penicillium brevi-compactum
Purity:≥98% (TLC)
Appearance:White solid.
Solubility:Soluble in DMSO (clear colorless solution at 50 mg/ml) or 100% ethanol.
Long Term Storage:-20°C
Use/Stability:Store solutions at -20°C for up to 3 months.
Please mouse over

Product Literature References

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil: A. C Allison et al.; Immunol. Rev. 136, 5 (1993), Abstract;
The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients: R.D. Ensley et al.; Transplantation 56, 75 (1993), Abstract;
Therapy of rheumatoid arthritis with mycophenolate mofetil: R. Goldblum; Clin. Exp. Rheumatol. 11 Suppl 8, S117 (1993), Abstract;
Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety: W.W. Epinette et al.; J. Am. Acad. Dermatol. 17, 962 (1987), Abstract;

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,